home / stock / eyes / eyes quote
Last: | $4.14 |
---|---|
Change Percent: | 123.78% |
Open: | $4.34 |
Close: | $1.85 |
High: | $4.35 |
Low: | $4.14 |
Volume: | 36,402 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.14 | $4.34 | $1.85 | $4.35 | $4.14 | 36,402 | 08-30-2022 |
$4.36 | $4.4 | $1.85 | $4.48 | $4.36 | 51,612 | 08-29-2022 |
$4.47 | $4.33 | $1.85 | $4.47 | $4.2 | 53,417 | 08-26-2022 |
$4.36 | $4.48 | $1.85 | $4.515 | $4.33 | 41,261 | 08-25-2022 |
$4.48 | $4.07 | $1.85 | $4.5212 | $4.05 | 99,781 | 08-24-2022 |
$4.11 | $4.17 | $1.85 | $4.27 | $4.05 | 133,478 | 08-23-2022 |
$4.18 | $4.27 | $1.85 | $4.3786 | $4.16 | 82,553 | 08-22-2022 |
$4.35 | $5 | $1.85 | $5.5 | $4.23 | 358,590 | 08-19-2022 |
$1.84 | $1.88 | $1.85 | $1.91 | $1.8 | 142,925 | 08-18-2022 |
$1.91 | $1.93 | $1.85 | $1.9444 | $1.84 | 630,330 | 08-17-2022 |
$1.92 | $2.01 | $1.85 | $2.07 | $1.86 | 936,368 | 08-16-2022 |
$2.01 | $2.05 | $1.85 | $2.09 | $2.0083 | 62,612 | 08-15-2022 |
$2.04 | $2.01 | $1.85 | $2.06 | $1.9851 | 111,971 | 08-12-2022 |
$2.03 | $2.09 | $1.85 | $2.11 | $1.98 | 145,177 | 08-11-2022 |
$2.05 | $2 | $1.85 | $2.07 | $1.9697 | 63,670 | 08-10-2022 |
$1.96 | $2 | $1.85 | $2.03 | $1.93 | 118,984 | 08-09-2022 |
$2.02 | $2.06 | $1.85 | $2.15 | $2 | 193,116 | 08-08-2022 |
$2.07 | $2 | $1.85 | $2.08 | $1.983 | 121,619 | 08-05-2022 |
$2.04 | $1.97 | $1.85 | $2.045 | $1.91 | 214,796 | 08-04-2022 |
$2 | $1.9 | $1.85 | $2.06 | $1.86 | 1,355,654 | 08-03-2022 |
News, Short Squeeze, Breakout and More Instantly...
Second Sight Medical Products Inc. Company Name:
EYES Stock Symbol:
NASDAQ Market:
Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...
Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...
Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...